While previous studies have identified genomic similarities between BOTs and other ovarian cancer types, including common mutations in KRAS and BRAF [7, 8, 9, 10], the transcriptomic parallels we observed between BOTs and ECs represent a novel finding. Here, KRAS is linked to ovarian carcinoma.